派博傳思國(guó)際中心

標(biāo)題: SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影響因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (IMMUN [打印本頁]

作者: GERM    時(shí)間: 2025-3-21 19:35
SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)影響因子


SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)影響因子@(免疫學(xué))學(xué)科排名


SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)總引論文


SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)總引論文@(免疫學(xué))學(xué)科排名


SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)影響因子


SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)總引頻次@(免疫學(xué))學(xué)科排名


SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)即時(shí)影響因子


SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)即時(shí)影響因子@(免疫學(xué))學(xué)科排名


SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(20 21 REV HIST)五年累積影響因子


SCIE(SCI)期刊Endocrine Metabolic & Immune Disorders-Drug Targets(ENDOCR METAB IMMUNE)五年累積影響因子@(免疫學(xué))學(xué)科排名



作者: Digest    時(shí)間: 2025-3-21 23:23
Submitted on: 03 July 2015. Revised on: 20 October 2015. Accepted on: 15 December 2015. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: scrutiny    時(shí)間: 2025-3-22 01:52
Submitted on: 19 May 2008. Revised on: 04 August 2008. Accepted on: 25 September 2008. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: 失眠癥    時(shí)間: 2025-3-22 07:30
Submitted on: 07 July 2012. Revised on: 27 July 2012. Accepted on: 02 September 2012. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: 平項(xiàng)山    時(shí)間: 2025-3-22 10:54
Submitted on: 10 September 2020. Revised on: 04 October 2020. Accepted on: 14 October 2020. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: Inscrutable    時(shí)間: 2025-3-22 14:27
Submitted on: 10 February 2023. Revised on: 16 May 2023. Accepted on: 12 June 2023. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: Dysarthria    時(shí)間: 2025-3-22 19:09

作者: Hemiplegia    時(shí)間: 2025-3-22 21:18

作者: catagen    時(shí)間: 2025-3-23 05:23
Submitted on: 17 May 2002. Revised on: 01 August 2002. Accepted on: 13 August 2002. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: 1分開    時(shí)間: 2025-3-23 06:41
Submitted on: 24 February 2004. Revised on: 18 May 2004. Accepted on: 05 July 2004. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: 館長(zhǎng)    時(shí)間: 2025-3-23 13:02

作者: ADOPT    時(shí)間: 2025-3-23 14:30

作者: 抵消    時(shí)間: 2025-3-23 19:00
Submitted on: 29 September 2013. Revised on: 17 January 2014. Accepted on: 24 February 2014. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: 不怕任性    時(shí)間: 2025-3-24 00:02
Submitted on: 16 November 2005. Revised on: 13 January 2006. Accepted on: 07 March 2006. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: Allege    時(shí)間: 2025-3-24 03:27

作者: labyrinth    時(shí)間: 2025-3-24 07:23
Submitted on: 21 May 1999. Revised on: 09 August 1999. Accepted on: 20 August 1999. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: disparage    時(shí)間: 2025-3-24 13:28
Submitted on: 20 December 2004. Revised on: 11 April 2005. Accepted on: 17 May 2005. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: 裝入膠囊    時(shí)間: 2025-3-24 15:42

作者: 座右銘    時(shí)間: 2025-3-24 22:26
Submitted on: 02 March 2002. Revised on: 27 June 2002. Accepted on: 27 July 2002. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: prolate    時(shí)間: 2025-3-25 02:49
Submitted on: 23 January 2010. Revised on: 04 March 2010. Accepted on: 24 March 2010. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: Anticlimax    時(shí)間: 2025-3-25 04:59
Submitted on: 02 November 2022. Revised on: 04 January 2023. Accepted on: 17 February 2023. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: construct    時(shí)間: 2025-3-25 08:15

作者: 玩笑    時(shí)間: 2025-3-25 11:54

作者: syncope    時(shí)間: 2025-3-25 19:52
Submitted on: 17 February 2009. Revised on: 03 May 2009. Accepted on: 16 June 2009. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: 同位素    時(shí)間: 2025-3-25 21:43
Submitted on: 22 December 2010. Revised on: 08 February 2011. Accepted on: 12 March 2011. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: 態(tài)度暖昧    時(shí)間: 2025-3-26 01:38

作者: 和音    時(shí)間: 2025-3-26 05:23

作者: CRASS    時(shí)間: 2025-3-26 08:48

作者: 邊緣    時(shí)間: 2025-3-26 15:51
Submitted on: 02 November 2022. Revised on: 24 February 2023. Accepted on: 19 April 2023. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: aquatic    時(shí)間: 2025-3-26 19:28
Submitted on: 22 March 2019. Revised on: 16 July 2019. Accepted on: 08 August 2019. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
作者: 血友病    時(shí)間: 2025-3-27 00:33

作者: BUCK    時(shí)間: 2025-3-27 04:23

作者: Thymus    時(shí)間: 2025-3-27 07:12

作者: Inkling    時(shí)間: 2025-3-27 11:32

作者: 傲慢物    時(shí)間: 2025-3-27 15:04

作者: fidelity    時(shí)間: 2025-3-27 20:42
Submitted on: 24 April 2007. Revised on: 09 July 2007. Accepted on: 09 August 2007. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets




歡迎光臨 派博傳思國(guó)際中心 (http://pjsxioz.cn/) Powered by Discuz! X3.5
江口县| 治县。| 神农架林区| 靖江市| 北流市| 吉水县| 定安县| 潜山县| 哈密市| 临漳县| 乌恰县| 宜良县| 简阳市| 湘潭市| 五大连池市| 略阳县| 东乡族自治县| 汉川市| 万宁市| 观塘区| 磐安县| 汶川县| 兴宁市| 济阳县| 南通市| 苏尼特右旗| 秦皇岛市| 延长县| 上饶县| 栾城县| 金坛市| 桂林市| 安福县| 永登县| 福贡县| 卢龙县| 北碚区| 罗山县| 雷波县| 城市| 惠来县|